Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02861209 | Collaborative Network to Take Responsibility for Oral Anticancer Therapy(CONTACT) | unknown | N/A | 228 | KU LeuvenOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03912857 | Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03904537 | A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer | unknown | Phase 1 / Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT01863862 | Organ Preservation in Elderly Patients With Rectal Cancer | unknown | N/A | 90 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Mar 29, 2019 | clinicaltrials |
| NCT02640781 | Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction | unknown | N/A | 70 | Yonsei UniversityOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT03880877 | Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer | unknown | Phase 2 | 153 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT03711240 | The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases(CBL) | unknown | Phase 2 | 40 | National Cheng-Kung University HospitalOTHER | 1 | Mar 13, 2019 | clinicaltrials |
| NCT03526952 | An Internet Delivered Intervention for Re-Adjustment to Sexual Intimacy With an Ostomy After Cancer | unknown | N/A | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Mar 12, 2019 | clinicaltrials |
| NCT03868215 | Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis | unknown | — | 100 | Fudan UniversityOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03436719 | Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics. | unknown | N/A | 280 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Mar 5, 2019 | clinicaltrials |
| NCT03422601 | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment | unknown | — | 1,122 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03312374 | ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer | unknown | — | 350 | Sun Yat-sen UniversityOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | unknown | N/A | 24 | Changhai HospitalOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT02624726 | Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment(MINOAS) | unknown | Phase 2 | 31 | Hellenic Oncology Research GroupOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03846882 | FDG - PET / MRI in Patients With Rectal Cancer(RECTOPET) | unknown | — | 100 | Region VästerbottenOTHER_GOV | 1 | Feb 20, 2019 | clinicaltrials |
| NCT02792023 | Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)(IDAFIT) | unknown | N/A | 550 | Hospital Universitario de CanariasOTHER | 1 | Feb 19, 2019 | clinicaltrials |
| NCT03843398 | Survival Outcome After Minilaparotomy for the Treatment of Colorectal Cancer(SoMiniCRC) | unknown | N/A | 992 | Changhai HospitalOTHER | 0 | Feb 18, 2019 | clinicaltrials |
| NCT03843749 | Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar. | unknown | N/A | 30 | Shanghai Changzheng HospitalOTHER | 1 | Feb 18, 2019 | clinicaltrials |
| NCT03329183 | High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 | unknown | Phase 2 | 90 | Shanghai Changzheng HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03792568 | ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation. | unknown | N/A | 30 | Shanghai Changzheng HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03828396 | Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures | unknown | — | 1,300 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 4, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03826862 | Lateral Lymph Node Dissection for Middle-low Rectal Cancer | unknown | N/A | 30 | Ziqiang Wang,MDOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03824899 | UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03823079 | Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 0 | Jan 30, 2019 | clinicaltrials |
| NCT01271582 | Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients | unknown | Phase 4 | 1,500 | Asan Medical CenterOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02311803 | Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery | unknown | N/A | 172 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02648386 | Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery | unknown | Phase 1 / Phase 2 | 34 | Chinese Academy of SciencesOTHER_GOV | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03040180 | Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer(nECT) | unknown | Phase 2 | 40 | Zealand University HospitalOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03702985 | Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03725254 | CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC | unknown | Phase 2 | 180 | Fudan UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03273231 | The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection | unknown | N/A | 100 | Yonsei UniversityOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT03052335 | The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening | unknown | N/A | 230 | Military University Hospital, PragueOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03289988 | Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression | unknown | — | 964 | Yonsei UniversityOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03803891 | Endoscopic Full-Thickness Resection In Colon(EFTRICOM) | unknown | — | 65 | Fundació Institut Germans Trias i PujolOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT00903565 | A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint(PARSC) | unknown | — | 1,200 | AgendiaINDUSTRY | 12 | Jan 9, 2019 | clinicaltrials |
| NCT03790475 | Participation in Competing Strategies for Colorectal Cancer Screening - a Randomized Health Services Study Within the National Screening Program in Poland(PICCOLINO) | unknown | N/A | 12,298 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Dec 31, 2018 | clinicaltrials |
| NCT03781193 | Psychological Predictors in Colorectal Cancer Surgery Recovery(MIND) | unknown | — | 40 | Istituto Clinico HumanitasOTHER | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03759548 | Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast Cancer | unknown | — | 100 | Federal University of Minas GeraisOTHER | 1 | Nov 30, 2018 | clinicaltrials |
| NCT03295591 | Circulating Tumor Cells in mCRC for Liver Resection | unknown | — | 77 | The University of Hong KongOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03731754 | "Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection(CCRPWAR) | unknown | N/A | 346 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Nov 9, 2018 | clinicaltrials |
| NCT03562234 | The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases(CLiFF) | unknown | — | 35 | University of ManchesterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03418558 | Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.(RESCUE) | unknown | Phase 2 | 13 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT03225937 | Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer(HERACLES) | unknown | Phase 2 | 54 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT03350412 | Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials(FUNNEL) | unknown | — | 1,000 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Oct 30, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Apr 16, 2019source: clinicaltrials